ATORVALIQ
- Strength
- 20 mg/5mL
- Form
- Suspension
- Class
- HMG-CoA Reductase Inhibitor
CMP Pharma, Inc.
Listed by Macleods Pharmaceuticals Limited
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | HMG-CoA Reductase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 33342-317 |
| FDA application | ANDA208480 |
| RxNorm concept | 259255 |
| Package sizes listed | 5 |
| Marketed since | June 2024 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
CMP Pharma, Inc.
Bryant Ranch Prepack
DIRECT RX
Novadoz Pharmaceuticals LLC
Radha Pharmaceuticals, Inc.
Camber Pharmaceuticals, Inc.
Laurus Labs Limited
A-S Medication Solutions
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.